Project Number 1R21AG067016-01 Agency/Funding Organization NIA Funding Year 2020 View Full Project Details for A personalized medicine approach to the study of monoamine brain systems that underlie the emergence of neuropsychiatric symptoms in person with Alzheimer's disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 10. Clinical Therapy Development for the Neuropsychiatric Symptoms of Dementia a. Pharmacological Category F. Research Resources 6. Disease Models e. iPS Cells Researcher and Organization Principal Investigator MACHAIRAKI, VASILIKI Principal Investigator First Name VASILIKI Principal Investigator Last Name MACHAIRAKI Awardee Organization JOHNS HOPKINS UNIVERSITY Awardee State Maryland Contact PI Country United States Project Detail Funding Opportunity Announcement RFA-MH-19-511: Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimers Dementia (R21 Clinical Trial Optional) FY Overall Cost $450,313 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official WISE, BRADLEY C
